Showing results (11-20 of 30) with videos related to
Sort By:
Pageof 3
European Urology|December 1, 1998
Water as a tumoricidal agent in bladder cancer. In vitro studies in parental and resistant cell linesL Z Solomon, B R Birch, A J CooperJournal of Clinical Pathology|November 1, 1984
Antibiotic susceptibility and biochemical properties of Streptococcus faecalis strains reacting with both D and G antiseraB R Birch, M G Keaney, L A GanguliScandinavian Journal of Urology and Nephrology|September 1, 1995
Adenocarcinoma of the prostate and Eaton-Lambert syndrome. A previously unreported associationS K Agarawal, B R Birch, G F AbercrombieClinical Radiology|June 1, 1995
Case report: multiple epidermoid cysts of the testes--the ultrasound appearancesA J Sanderson, B R Birch, K C DewburyBritish Journal of Urology|October 1, 1990
Sedoanalgesia in urology: a safe, cost-effective alternative to general anaesthesia. A review of 1020 casesB R Birch, K M Anson, R A MillerHistopathology|December 1, 1991
Evaluation of endothelial markers in detecting blood and lymphatic channel invasion in pT1 transitional carcinoma of bladderP Ramani, B R Birch, S J Harland, et al.Journal of the Royal Society of Medicine|July 1, 1990
Day-case surgery: enhanced recovery with flumazenilB R Birch, K M Anson, E Clifford, et al.BJU International|February 13, 2001
Cellular resistance to mitomycin C is associated with overexpression of MDR-1 in a urothelial cancer cell line (MGH-U1)M C Hayes, B R Birch, A J Cooper, et al.Acta Anaesthesiologica Scandinavica. Supplementum|January 1, 1990
The role of midazolam and flumazenil in urologyB R Birch, K Anson, J Gelister, et al.Annals of the Royal College of Surgeons of England|November 1, 1991
Sedation for day-case urology: an assessment of patient recovery profiles after midazolam and flumazenilB R Birch, K M Anson, D V Kalmanovitch, et al.Pageof 3